Search for publications

Search results

4733 items matching your search terms.

Effect of a hybrid closed-loop system on glycemic and psychosocial outcomes in children and adolescents with Type 1 diabetes: A randomized clinical trial

Abraham, M. B. de Bock, M. Smith, G. J. Dart, J. Fairchild, J. M. King, B. R. Ambler, G. R. Cameron, F. J. McAuley, S. A. Keech, A. C. Jenkins, A. Davis, E. A. O'Neal, D. N. Jones, T. W. Australian Juvenile Diabetes Research Fund Closed-Loop Research, group
JAMA PEDIATR, 2021     DOI:10.1001/jamapediatrics.2021.3965

Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial

Ackermann, D. M. Smit, A. K. Janda, M. van Kemenade, C. H. Dieng, M. Morton, R. L. Turner, R. M. Cust, A. E. Irwig, L. Hersch, J. K. Guitera, P. Soyer, H. P. Mar, V. Saw, R. P. M. Low, D. Low, C. Drabarek, D. Espinoza, D. Emery, J. Murchie, P. Thompson, J. F. Scolyer, R. A. Azzi, A. Lilleyman, A. Bell, K. J. L.
TRIALS, 2021     DOI:10.1186/s13063-021-05231-7

Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines

Agarwal, A. Livingstone, A. Karikios, D. J. Stockler, M. R. Beale, P. J. Morton, R. L.
BMC CANCER, 2021     DOI:10.1186/s12885-021-08697-5

Differential levels of mRNAs in normal B lymphocytes, monoclonal B lymphocytosis and chronic lymphocytic leukemia cells from the same family identify susceptibility genes

Alshahrani, A. Skarratt, K. K. Robledo, K. P. Hassanvand, M. Tang, B. Fuller, S. J.
ONCOL THER, 2021     DOI:10.1007/s40487-021-00172-2

Improvement in epistaxis management: The experience of a dedicated hereditary haemorrhagic telangiectasia clinic

Anning, R. Huang, J. Ronan, A. de Malmanche, J. Asher, R. Low, T. H.
ANZ JOURNAL OF SURGERY, 2021     DOI:10.1111/ans.17322

Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial

Antill, Y. Kok, P. S. Robledo, K. Yip, S. Cummins, M. Smith, D. Spurdle, A. Barnes, E. Lee, Y. C. Friedlander, M. Baron-Hay, S. Shannon, C. Coward, J. Beale, P. Goss, G. Meniawy, T. Lombard, J. Andrews, J. Stockler, M. R. Mileshkin, L. Australia New Zealand Gynaecological Oncology, Group
J IMMUNOTHER CANCER, 2021     DOI:10.1136/jitc-2020-002255

Peripheral neuropathy: An important contributor to physical limitation and morbidity in stage 3-4 chronic kidney disease

Arnold, R. Pianta, T. J. Issar, T. Kirby, A. Scales, C. Kwai, N. Endre, Z. Krishnan, A. V.
NEPHROLOGY, DIALYSIS, TRANSPLANTATION, 2021     DOI:10.1093/ndt/gfab043

The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial

Arnott, C. Li, J. W. Cannon, C. P. de Zeeuw, D. Neuen, B. L. Heerspink, H. J. L. Charytan, D. M. Agarwal, A. Huffman, M. D. Figtree, G. A. Bakris, G. Chang, T. I. Feng, K. Rosenthal, N. Zinman, B. Jardine, M. J. Perkovic, V. Neal, B. Mahaffey, K. W.
DIABETES, OBESITY AND METABOLISM, 2021     DOI:10.1111/dom.14386

A model of culturally-informed integrated diabetes education and eye screening in indigenous primary care services and specialist diabetes clinics: Study protocol

Atkinson-Briggs, S. Jenkins, A. Keech, A. Ryan, C. Brazionis, L. Centre of Research Excellence in Diabetic Retinopathy Study, Group
JOURNAL OF ADVANCED NURSING, 2021     DOI:10.1111/jan.14734

Investigating inducible muscle overactivity in acquired brain injury and the impact of Botulinum Toxin A

Baguley, I. J. Barden, H. L. Byth, K.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2021     DOI:10.1016/j.apmr.2021.07.802

Investigating inducible muscle overactivity in acquired brain injury and the impact of Botulinum Toxin A

Baguley, I. J. Barden, H. L. Byth, K.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2021     DOI:10.1016/j.apmr.2021.07.802

A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trial

Banerjee, S. N. Tang, M. O'Connell, R. L. Sjoquist, K. Clamp, A. R. Millan, D. Nottley, S. Lord, R. Mullassery, V. M. Hall, M. Gourley, C. Bonaventura, T. Goh, J. C. Sykes, P. Grant, P. T. McNally, O. Alexander, L. Kelly, C. Carty, K. Divers, L. Bradshaw, N. Edmondson, R. J. Friedlander, M. Paragon investigators
GYNECOLOGIC ONCOLOGY, 2021     DOI:10.1016/j.ygyno.2021.07.024

Patients' preferences for 3 months vs 6 months of adjuvant chemotherapy for colon cancer

Blinman, P. Martin, A. Jefford, M. Goldstein, D. Boadle, D. Morris, M. Tebbutt, N. Aiken, C. Harkin, A. Segelov, E. Haydon, A. Iveson, T. Stockler, M. R.
JNCI CANCER SPECTR, 2021     DOI:10.1093/jncics/pkaa107

Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic review

Blood, Z. Tran, A. Caleo, L. Saw, R. Dieng, M. Shackleton, M. Soyer, H. P. Arnold, C. Mann, G. J. Morton, R. L.
BMJ OPEN, 2021     DOI:10.1136/bmjopen-2020-040751